Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06222398 · ClinicalTrials.gov registry record
Exoskeleton Use With In Home Functional Activities
A clinical trial, sponsored by A.T. Still University of Health Sciences.
- Terminated
- Registry status
- 12
- Enrollment target
NCT06222398: Clinical Trial study, sponsored by A.T. Still University of Health Sciences.
NCT06222398 is a clinical trial that was terminated before completion, run by A.T. Still University of Health Sciences. The registered enrollment target is 12 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06222398 was terminated before completion, sponsored by A.T. Still University of Health Sciences.
- TERMINATED
- Registry status
- 12 participants
- Enrollment target
Study Summary
The purpose of this study is to observe current exoskeleton users in their home environment to determine the activities of daily living (ADLs) they are able to complete, and to identify the minor adaptations to the home environment that will improve the exoskeleton user's potential for increased independence. This is a pilot study to fine-tune the methods and to determine the feasibility of doing this study on a larger scale.
Primary Outcome
Assesses quantitatively the degree to which individuals who have experienced traumatic or incapacitating illness achieve reintegration into normal social activities. This assessment has been modified from wheelchair level to exoskeleton level. The Reintegration to Normal Living Index has 9 Likert-style items. Each item is accompanied by verbal label choices with phrases reflecting how important the situation described is to the patient as it relates to using the exoskeleton. It allows the patien
Interventions
- DEVICE Exoskeleton
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2024-02-10 |
| Est. Completion | 2025-12-28 |
Why NCT06222398 stopped before completion
NCT06222398 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 12 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Exoskeleton is the first listed.
NCT06222398 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06222398 about?
NCT06222398 is a clinical study titled "Exoskeleton Use With In Home Functional Activities". The purpose of this study is to observe current exoskeleton users in their home environment to determine the activities of daily living (ADLs) they are able to complete, and to identify the minor adaptations to the home environment that will improve the exoskeleton user's potential for increased ind...
What is the current status of trial NCT06222398?
This trial is currently terminated. The enrollment target is 12 participants. The study started on 2024-02-10. Estimated completion is 2025-12-28.
What interventions are being tested in trial NCT06222398?
The interventions under investigation include: Exoskeleton (DEVICE).
Who is sponsoring clinical trial NCT06222398?
This trial is sponsored by A.T. Still University of Health Sciences, which has 16 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02602769 · 12 participants
Whole Transcriptome Profiling and Metabolic Phenotyping in Children With ROHHAD Syndrome
- NCT02605421 · 12 participants · Phase 2
Myeloablative Consolidation Therapy and Tandem Autologous Stem Cell Rescue in Patients With High-Risk Neuroblastoma
- NCT02619448 · 12 participants · Early Phase 1
Concurrent Chemotherapy Plus HFR Radiation Therapy in Inoperable NSCLC
- NCT03311503 · 12 participants · Phase 1
Phase I/II Trial of Lentiviral Gene Transfer for SCID-X1 With Low Dose Targeted Busulfan Conditioning
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI